-
Something wrong with this record ?
Resveratrol suppresses ethanol stress in winery and bottom brewery yeast by affecting superoxide dismutase, lipid peroxidation and fatty acid profile
L. Gharwalova, K. Sigler, J. Dolezalova, J. Masak, T. Rezanka, I. Kolouchova,
Language English Country Germany
Document type Journal Article
NLK
ProQuest Central
from 1997-01-01 to 2017-12-31
Health & Medicine (ProQuest)
from 1997-01-01 to 2017-12-31
- MeSH
- Antioxidants metabolism MeSH
- Ethanol pharmacology MeSH
- Stress, Physiological drug effects MeSH
- Lipids physiology MeSH
- Fatty Acids metabolism MeSH
- Lipid Metabolism drug effects MeSH
- Lipid Peroxidation drug effects MeSH
- Saccharomyces cerevisiae drug effects MeSH
- Stilbenes pharmacology MeSH
- Superoxide Dismutase metabolism MeSH
- Wine microbiology MeSH
- Publication type
- Journal Article MeSH
Mid-exponential cultures of two traditional biotechnological yeast species, winery Saccharomyces cerevisiae and the less ethanol tolerant bottom-fermenting brewery Saccharomyces pastorianus, were exposed to different concentrations of added ethanol (3, 5 and 8%) The degree of ethanol-induced cell stress was assessed by measuring the cellular activity of superoxide dismutase (SOD), level of lipid peroxidation products, changes in cell lipid content and fatty acid profile. The resveratrol as an antioxidant was found to decrease the ethanol-induced rise of SOD activity and suppress the ethanol-induced decrease in cell lipids. A lower resveratrol concentration (0.5 mg/l) even reduced the extent of lipid peroxidation in cells. Resveratrol also alleviated ethanol-induced changes in cell lipid composition in both species by strongly enhancing the proportion of saturated fatty acids and contributing thereby to membrane stabilization. Lower resveratrol concentrations could thus diminish the negative effects of ethanol stress on yeast cells and improve their physiological state. These effects may be utilized to enhance yeast vitality in high-ethanol-producing fermentations or to increase the number of yeast generations in brewery.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016245
- 003
- CZ-PrNML
- 005
- 20180518142614.0
- 007
- ta
- 008
- 180515s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11274-017-2371-x $2 doi
- 035 __
- $a (PubMed)29101483
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Gharwalova, Lucia $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6 Dejvice, Czech Republic.
- 245 10
- $a Resveratrol suppresses ethanol stress in winery and bottom brewery yeast by affecting superoxide dismutase, lipid peroxidation and fatty acid profile / $c L. Gharwalova, K. Sigler, J. Dolezalova, J. Masak, T. Rezanka, I. Kolouchova,
- 520 9_
- $a Mid-exponential cultures of two traditional biotechnological yeast species, winery Saccharomyces cerevisiae and the less ethanol tolerant bottom-fermenting brewery Saccharomyces pastorianus, were exposed to different concentrations of added ethanol (3, 5 and 8%) The degree of ethanol-induced cell stress was assessed by measuring the cellular activity of superoxide dismutase (SOD), level of lipid peroxidation products, changes in cell lipid content and fatty acid profile. The resveratrol as an antioxidant was found to decrease the ethanol-induced rise of SOD activity and suppress the ethanol-induced decrease in cell lipids. A lower resveratrol concentration (0.5 mg/l) even reduced the extent of lipid peroxidation in cells. Resveratrol also alleviated ethanol-induced changes in cell lipid composition in both species by strongly enhancing the proportion of saturated fatty acids and contributing thereby to membrane stabilization. Lower resveratrol concentrations could thus diminish the negative effects of ethanol stress on yeast cells and improve their physiological state. These effects may be utilized to enhance yeast vitality in high-ethanol-producing fermentations or to increase the number of yeast generations in brewery.
- 650 _2
- $a antioxidancia $x metabolismus $7 D000975
- 650 _2
- $a ethanol $x farmakologie $7 D000431
- 650 _2
- $a mastné kyseliny $x metabolismus $7 D005227
- 650 _2
- $a metabolismus lipidů $x účinky léků $7 D050356
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a lipidy $x fyziologie $7 D008055
- 650 _2
- $a Saccharomyces cerevisiae $x účinky léků $7 D012441
- 650 _2
- $a stilbeny $x farmakologie $7 D013267
- 650 _2
- $a fyziologický stres $x účinky léků $7 D013312
- 650 _2
- $a superoxiddismutasa $x metabolismus $7 D013482
- 650 _2
- $a víno $x mikrobiologie $7 D014920
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sigler, Karel $u Institute of Microbiology, CAS, Vídeňská 1083, 142 20, Prague, Czech Republic.
- 700 1_
- $a Dolezalova, Jana $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6 Dejvice, Czech Republic.
- 700 1_
- $a Masak, Jan $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6 Dejvice, Czech Republic.
- 700 1_
- $a Rezanka, Tomas $u Institute of Microbiology, CAS, Vídeňská 1083, 142 20, Prague, Czech Republic.
- 700 1_
- $a Kolouchova, Irena $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6 Dejvice, Czech Republic. irena.kolouchova@vscht.cz.
- 773 0_
- $w MED00006402 $t World journal of microbiology & biotechnology $x 1573-0972 $g Roč. 33, č. 11 (2017), s. 205
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29101483 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180518142752 $b ABA008
- 999 __
- $a ok $b bmc $g 1299869 $s 1013085
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 33 $c 11 $d 205 $e 20171103 $i 1573-0972 $m World journal of microbiology & biotechnology incorporating the MIRCEN Journal of applied microbiology and biotechnology $n World j. microbiol. biotechnol. $x MED00006402
- LZP __
- $a Pubmed-20180515